当前位置: 首页 > 期刊 > 《上海医药》 > 2024年第11期
编号:2156263
233例依那西普不良反应文献分析
http://www.100md.com 2024年8月10日 上海医药 2024年第11期
     摘 要 目的:分析依那西普所致不良反应的临床表现和特点,为临床安全用药提供参考。方法:检索1998—2022年中国知网、万方、维普、PubMed、Web of Science、Embase数据库中关于依那西普致ADR的个案报道并进行分析。结果:收集个案报道204篇,不良反应最易发生时间为用药1年以上,结节病、系统性红斑狼疮最常见。最常累及皮肤、免疫系统、呼吸系统。多数患者支持治疗后好转,8例死亡。结论:依那西普相关不良反应发生时间较长,可累及多个器官/系统,多数患者对症治疗后好转/治愈,少数严重不良反应可致患者死亡,应提高警惕,及时监测,积极治疗。

    关键词 依那西普 不良反应 文献分析

    中图分类号:R971.1 文献标志码:C 文章编号:1006-1533(2024)11-0099-04

    引用本文 刘俊, 任艳丽, 赵庆贺, 等. 233例依那西普不良反应文献分析[J]. 上海医药, 2024, 45(11): 99-102.

    Literature analysis of 233 cases of adverse drug reactions induced by etanercept

    LIU Jun1, REN Yanli1, ZHAO Qinghe1, ZHOU Zongzhou2

    (1. Department of Pharmacy, the Third Hospital affiliated to Zhengzhou University, Zhengzhou 450052, China; 2. Foshan Food and Drug Inspection and Testing Center, Foshan 528051, China)

    ABSTRACT Objective: To explore the general characteristics of adverse drug reactions (ADR) induced by Etanercept, and provide reference for safe use of etanercept. Methods: The articles about etanercept published from 1998 to 2022 in CNKI, Wanfang, VIP, Web of Science, PubMed, Embase were searched. Results: A total of 204 articles were included with 233 cases. ADR frequently occurred 1 year after treatment. The diseases such as sarcoidosis and systemic lupus erythematosus were most common. Skin ......

您现在查看是摘要页,全文长 10017 字符